Mutation screening for the prothrombin variant G20210A by melting point analysis with the Light Cycler system: Atypical results, detection of the variant C20209T and possible clinical implications

Clinical and Laboratory Haematology

Volumn 27, Issue 5, 2005, Pages 343-346

  Wylenzek, C ^a   Trubenbach J ^b   Gohl, P ^b   Wildhardt, G ^b   Alkins, S ^c   Fausett, M B ^c   Decker, J ^d   Steinberger, Daniela ^b,e  

^a Hunsrueck Klinik   (Germany)

^b Bioscientia Center for Human Genetics   (Germany)

^c LANDSTUHL REGIONAL MEDICAL CENTER   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Deep venous thrombosis; Ethnic origin; Molecular genetic diagnostic; Mutation detection systems; Prothrombin variants

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; PROTHROMBIN; WARFARIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; ETHNOLOGY; FEMALE; GENOTYPE; HUMAN; LUNG EMBOLISM; MALE; MELTING POINT; MOLECULAR GENETICS; MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THROMBOPHILIA;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; HEAT; HUMANS; MALE; NUCLEIC ACID DENATURATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTHROMBIN; SEQUENCE ANALYSIS, DNA; THROMBOPHILIA;

EID: 26044447493     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2005.00720.x     Document Type: Article

References (8)

1. Chen F., MacDonald C.C. & Wilusz J. (1995) Cleavage site determinants in the mammalian polyadenylation signal. Nucleic Acids Research 23, 2614-2620.
2. Dahlback B. (2000) Blood coagulation. Lancet 355, 1627-1632.
3. Danckwardt S., Gehring N.H., Neu-Yilik G., Hundsdoerfer P., Pforsich M., Frede U., Hentze M.W. & Kulozik A.E. (2004) The prothrombin 3′end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. Blood 104, 428-435.
4. Degen S.J. & Davie B.W. (1987) Nucleotide sequence of the gene for human prothrombin. Biochemistry 26, 6165-6177.
5. Gehring N.H., Frede U., Neu-Yilik G., Hundsdoerfer P., Vetter B., Hentze M.W. & Kulozik A.E. (2001) Increased efficiency of mRNA 3′end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nature Genetics 28, 389-392.
6. Poort S.R., Rosendaal F.R., Reitsma P.H. & Bertina R.M. (1996) A common genetic variation in the 3≥-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88, 3698-3703.
7. Von Ahsen N., Schütz E., Armstrong V.W. & Oellerich M. (1999) Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A, and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with light cycler. Clinical Chemistry 45, 694-696.
8. Warshawsky I., Hren C., Sercia L., Shadrach B., Deitcher S.R., Newton E. & Kottke-Marchant K. (2002) Detection of a novel point mutation of the prothrombin gene at position 20209. Diagnostic Molecular Pathology 11, 152-156.